TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ilumab AB
Closing information (x1000 NOK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
264
|
447
|
426 |
| Financial expenses |
21
|
0
|
0 |
| Earnings before taxes |
239
|
344
|
333 |
| EBITDA |
261
|
353
|
337 |
| Total assets |
3,630
|
3,649
|
3,476 |
| Current assets |
3,519
|
3,619
|
3,463 |
| Current liabilities |
124
|
175
|
130 |
| Equity capital |
3,341
|
3,302
|
3,166 |
| - share capital |
100
|
99
|
97 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
92.0%
|
90.5%
|
91.1% |
| Turnover per employee |
264
|
447
|
426 |
| Profit as a percentage of turnover |
90.5%
|
77.0%
|
78.2% |
| Return on assets (ROA) |
7.2%
|
9.4%
|
9.6% |
| Current ratio |
2837.9%
|
2068.0%
|
2663.8% |
| Return on equity (ROE) |
7.2%
|
10.4%
|
10.5% |
| Change turnover |
-189
|
12
|
16 |
| Change turnover % |
-42%
|
3%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.